{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:02:02Z","timestamp":1773280922997,"version":"3.50.1"},"reference-count":30,"publisher":"China Science Publishing & Media Ltd.","issue":"4","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2010,4,1]]},"DOI":"10.1093\/abbs\/gmq012","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T01:19:12Z","timestamp":1267665552000},"page":"253-258","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":28,"title":["MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals"],"prefix":"10.3724","volume":"42","author":[{"given":"Baolin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuedong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongsen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaojun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"Frey N","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target?. Circulation, 2004, 109: 1580-1589.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1152\/physrev.00032.2006","volume":"87","author":"Ahuja P","year":"2007","unstructured":"Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev, 2007, 87: 521-544.","journal-title":"Physiol Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","volume":"82","author":"Glickman MH","year":"2002","unstructured":"Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev, 2002, 82: 373-428.","journal-title":"Physiol Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.107.097816","volume":"51","author":"Meiners S","year":"2008","unstructured":"Meiners S, Dreger H, Fechner M, Bieler S, Rother W, Gunther C, Baumann G. Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Hypertension, 2008, 51: 302-308.","journal-title":"Hypertension"},{"key":"null","doi-asserted-by":"crossref","unstructured":"Palombella VJ Rando OJ Goldberg AL Maniatis T The ubiquitin-proteasome pathway is required for processing the NF-\u03baB1 precursor protein and the activation of NF-\u03baB. Cell 1994 773 785 78.","DOI":"10.1016\/S0092-8674(94)90482-0"},{"key":"null","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bj3280037","volume":"328","author":"Folco EJ","year":"1997","unstructured":"Folco EJ, Koren G. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem J, 1997, 328: 37-43.","journal-title":"Biochem J"},{"key":"null","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/ars.2005.7.538","volume":"7","author":"Powell SR","year":"2005","unstructured":"Powell SR, Wang P, Katzeff H, Shringarpure R, Teoh C, Khaliulin I, Das DK. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal, 2005, 7: 538-546.","journal-title":"Antioxid Redox Signal"},{"key":"null","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1096\/fj.05-3973fje","volume":"19","author":"Kumarapeli AR","year":"2005","unstructured":"Kumarapeli AR, Horak KM, Glasford JW, Li J, Chen Q, Liu J, Zheng H. A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. FASEB J, 2005, 19: 2051-2053.","journal-title":"FASEB J"},{"key":"null","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.106.637827","volume":"114","author":"Depre C","year":"2006","unstructured":"Depre C, Wang Q, Yan L, Hedhli N, Peter P, Chen L, Hong C. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation, 2006, 114: 1821-1828.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jmb.2008.09.070","volume":"384","author":"Bahrudin U","year":"2008","unstructured":"Bahrudin U, Morisaki H, Morisaki T, Ninomiya H, Higaki K, Nanba E, Igawa O. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J Mol Biol, 2008, 384: 896-907.","journal-title":"J Mol Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardiores.2005.01.004","volume":"66","author":"Sarikas A","year":"2005","unstructured":"Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg KS, Eschenhagen T. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res, 2005, 66: 33-44.","journal-title":"Cardiovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bbrc.2006.12.039","volume":"353","author":"Doll D","year":"2007","unstructured":"Doll D, Sarikas A, Krajcik R, Zolk O. Proteomic expression analysis of cardiomyocytes subjected to proteasome inhibition. Biochem Biophys Res Commun, 2007, 353: 436-442.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1096\/fj.05-5495com","volume":"20","author":"Ding Q","year":"2006","unstructured":"Ding Q, Dimayuga E, Markesbery WR, Keller JN. Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J, 2006, 20: 1055-1063.","journal-title":"FASEB J"},{"key":"null","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/hc0402.102951","volume":"105","author":"Meiners S","year":"2002","unstructured":"Meiners S, Laule M, Rother W, Guenther C, Prauka I, Muschick P, Baumann G. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation, 2002, 105: 483-489.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1593\/tlo.08133","volume":"1","author":"Yuan BZ","year":"2008","unstructured":"Yuan BZ, Chapman JA, Reynolds SH. Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cells. Transl Oncol, 2008, 1: 129-140.","journal-title":"Transl Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bcp.2009.08.015","volume":"79","author":"Liu L","year":"2010","unstructured":"Liu L, Yang C, Herzog C, Seth R, Kaushal GP. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol, 2010, 79: 137-146.","journal-title":"Biochem Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrd2056","volume":"5","author":"Nalepa G","year":"2006","unstructured":"Nalepa G, Rolfe M, Harper JW. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov, 2006, 5: 596-613.","journal-title":"Nat Rev Drug Discov"},{"key":"null","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjc.6604730","volume":"99","author":"Diallo JS","year":"2008","unstructured":"Diallo JS, Betton B, Parent N, Peant B, Lessard L, Le PC, Bertrand R. Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors. Br J Cancer, 2008, 99: 1613-1622.","journal-title":"Br J Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2009.08.024","volume":"620","author":"Meng RS","year":"2009","unstructured":"Meng RS, Pei ZH, Yin R, Zhang CX, Chen BL, Zhang Y, Liu D. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway. Eur J Pharmacol, 2009, 620: 63-70.","journal-title":"Eur J Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cardiores.2005.12.021","volume":"70","author":"Zolk O","year":"2006","unstructured":"Zolk O, Schenke C, Sarikas A. The ubiquitin-proteasome system: focus on the heart. Cardiovasc Res, 2006, 70: 410-421.","journal-title":"Cardiovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJM199612193352507","volume":"335","author":"Mitch WE","year":"1996","unstructured":"Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med, 1996, 335: 1897-1905.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cvr\/cvp107","volume":"83","author":"Dreger H","year":"2009","unstructured":"Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, Stangl K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res, 2009, 83: 354-361.","journal-title":"Cardiovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0008-6363(02)00232-8","volume":"54","author":"Luss H","year":"2002","unstructured":"Luss H, Schmitz W, Neumann J. A proteasome inhibitor confers cardioprotection. Cardiovasc Res, 2002, 54: 140-151.","journal-title":"Cardiovasc Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Wang Y","year":"2007","unstructured":"Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation, 2007, 116: 1413-1423.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.103.10.1453","volume":"103","author":"Esposito G","year":"2001","unstructured":"Esposito G, Prasad SV, Rapacciuolo A, Mao L, Koch WJ, Rockman HA. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation, 2001, 103: 1453-1458.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.RES.0000161999.86198.1e","volume":"96","author":"Klein G","year":"2005","unstructured":"Klein G, Schaefer A, Hilfiker-Kleiner D, Oppermann D, Shukla P, Quint A, Podewski E. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ Res, 2005, 96: 748-755.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"Bueno OF","year":"2000","unstructured":"Bueno OF, de Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE. The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J, 2000, 19: 6341-6350.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1128\/MCB.24.3.1081-1095.2004","volume":"24","author":"Purcell NH","year":"2004","unstructured":"Purcell NH, Darwis D, Bueno OF, Muller JM, Schule R, Molkentin JD. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol, 2004, 24: 1081-1095.","journal-title":"Mol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/emboj\/cdg474","volume":"22","author":"Liang Q","year":"2003","unstructured":"Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J, 2003, 22: 5079-5089.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"Frey N","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol, 2003, 65: 45-79.","journal-title":"Annu Rev Physiol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/0D4EF26D9C3046B29600C47F41AC7276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmq012","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/0D4EF26D9C3046B29600C47F41AC7276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T16:26:28Z","timestamp":1711297588000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmq012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,4,1]]},"published-print":{"date-parts":[[2010,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmq012","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,1]]}}}